Uniqlife Biosciences Private Limited

Uniqlife Biosciences Private Limited - pharma in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U51101UP2012PTC050651 Incorporated 24 May 2012 ROC Kanpur HQ Agra, Uttar Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹9.34 Cr
▲ 18% YoY
Net profit · FY 2025
₹27.8 Lakh
Net margin 3%
EBITDA · FY 2025
₹98.7 Lakh
EBITDA margin 10.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7 Lakh
Issued & subscribed
Open charges
₹4.14 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
33
Provident fund records

About Uniqlife Biosciences Private Limited

Data last updated:

Uniqlife Biosciences Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 May 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51101UP2012PTC050651. Its GSTIN is 09AABCU4540K1Z5 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Neeraj Sharma and Pinkey Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Satyam Multiplex Office No. 7 First Floor 103 Sector 12A Avas Vikas Colony, Agra, Uttar Pradesh, India – 282007.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.34 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹27.8 Lakh (net margin 3%) and EBITDA of ₹98.7 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 12% over five years.

The company has about 33 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Uniqlife BioSciences. As per MCA filings, the company has open charges of ₹4.14 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website uniqlife.in.

Company details

CIN U51101UP2012PTC050651
Registration Number 050651
Incorporation Date 24 May 2012
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Uniqlife Biosciences Private Limited's registered office is in Agra, Uttar Pradesh. Its website is uniqlife.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Satyam Multiplex Office No. 7 First Floor 103 Sector 12A Avas Vikas Colony, Agra, Uttar Pradesh, India – 282007
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Uniqlife Biosciences Private Limited, buy the company report.

Comprehensive company report
Uniqlife Biosciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Uniqlife Biosciences operates one associated brand: Uniqlife BioSciences. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing and supplying pharmaceutical medicines and injections under WHO standards in India.uniqlife.in

Business activity

The main business activity of Uniqlife Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Uniqlife Biosciences Private Limited, buy the company report.

Financials of Uniqlife Biosciences Private Limited

FY 2025 filings available

Uniqlife Biosciences Private Limited reported revenue of ₹9.34 Cr (up 18% YoY) for FY 2025.

Revenue · FY 2025
₹9.34 Cr ▲ 18%
Net profit · FY 2025
₹27.8 Lakh margin 3%
EBITDA · FY 2025
₹98.7 Lakh margin 10.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 7%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 9%
5 years · compounded
▲ 7%

Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 18% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹98.7 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹27.8 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.6%
Net Profit Margin3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Uniqlife Biosciences Private Limited, buy the company report.

Board of directors of Uniqlife Biosciences Private Limited

Uniqlife Biosciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Neeraj SharmaDirector01 Feb 201412 Years 9 MonthsCurrent
Pinkey SharmaDirector24 May 201214 Years 5 MonthsCurrent

Peer comparison

Uniqlife Biosciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Osbro Pharmaceutical Private Limited₹9.34 Cr (FY 2022)-11.0%Pune, Maharashtra, India
Uniqlife Biosciences Private Limitedthis company₹9.34 Cr (FY 2025)₹27.8 Lakh3%18.0%33Agra, Uttar Pradesh, India
Idealife Healthcare Limited₹9.32 Cr (FY 2025)11.0%Kanpur, Uttar Pradesh, India
Palmo Industrial Silicones Private Limited₹9.32 Cr (FY 2025)7.0%Vadodara, Gujarat, India
Poddar Pharmaceuticals Private Limited₹9.25 Cr (FY 2024)83.0%Uttar Pradesh, India
Thio Chemi Private Limited₹9.24 Cr (FY 2025)55.0%Coimbatore, Tamil Nadu, India

To see the full peer comparison of Uniqlife Biosciences Private Limited, buy the company report.

Auditor

Uniqlife Biosciences Private Limited is audited by A.C.H.G & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
A.C.H.G & ASSOCIATESFY 2023012705C

Shareholding

The shareholding of Uniqlife Biosciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Uniqlife Biosciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.14 Cr
Satisfied charges
None
Breakdown by lending institutions
Indian Overseas Bank₹4.14 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Mar 2024100907928Indian Overseas Bank₹15 LakhOpen
30 Sep 2023100816245Indian Overseas Bank₹13.5 LakhOpen
18 Oct 2022100627879Indian Overseas Bank₹10 LakhOpen
31 Aug 2022100627885Indian Overseas Bank₹33 LakhOpen
15 Jul 2020100357504Indian Overseas Bank₹27 LakhOpen

To see the full charge records of Uniqlife Biosciences Private Limited, buy the company report.

Total charge records: 7 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Uniqlife Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Uniqlife Biosciences Private Limited has a workforce of 33 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
33
Active EPFO establishments
1
Employee growth
26.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2733
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Uniqlife Biosciences Private Limited, buy the company report.

GST

Uniqlife Biosciences has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AABCU4540K1Z5Uttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Uniqlife Biosciences Private Limited, buy the company report.

Recent activity

Uniqlife Biosciences Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Rajendra Kumar Sharma ceased to be Director on 17 Mar 2017.

AGM
Uniqlife Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Uniqlife Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Indian Overseas Bank of Rs. 300.00 Lakh registered on 29 May 2015 with Charge ID 10581657 was modified on 03 Jun 2024.
Charges
A charge with Indian Overseas Bank amounted to Rs. 15.00 Lakh with Charge ID 100907928 was registered on 01 Mar 2024.
Charges
A charge with Indian Overseas Bank amounted to Rs. 13.50 Lakh with Charge ID 100816245 was registered on 30 Sep 2023.
Charges
A charge with Indian Overseas Bank amounted to Rs. 10.00 Lakh with Charge ID 100627879 was registered on 18 Oct 2022.
Charges
A charge with Indian Overseas Bank amounted to Rs. 33.00 Lakh with Charge ID 100627885 was registered on 31 Aug 2022.
Charges
A charge with Indian Overseas Bank amounted to Rs. 27.00 Lakh with Charge ID 100357504 was registered on 15 Jul 2020.
Charges
A charge with Indian Overseas Bank amounted to Rs. 15.00 Lakh with Charge ID 100250581 was registered on 13 Mar 2019.
Ceased
Rajendra Kumar Sharma ceased to be Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 300.00 Lakh with Charge ID 10581657 was registered on 29 May 2015.
Appointed
Neeraj Sharma was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

Uniqlife Biosciences is an active private limited company based in Agra, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 May 2012 (14+ years old) and is registered under CIN U51101UP2012PTC050651.

Uniqlife Biosciences has 2 current directors:

The latest financial statements of Uniqlife Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Uniqlife Biosciences is 09AABCU4540K1Z5, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Uniqlife Biosciences is U51101UP2012PTC050651. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Uniqlife Biosciences was incorporated on 24 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Uniqlife Biosciences by revenue are Osbro Pharmaceutical Private Limited, Idealife Healthcare Limited, Palmo Industrial Silicones Private Limited, Poddar Pharmaceuticals Private Limited, Thio Chemi Private Limited, all in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rajendra Kumar Sharma ceased to be Director on 17 Mar 2017. Neeraj Sharma was appointed as Director on 01 Feb 2014. Neeraj Sharma ceased to be Director on 05 Aug 2013. Uniqlife Biosciences has 4 board changes on record in total.

Uniqlife Biosciences can be reached through the website uniqlife.in. Its registered office is in Agra, Uttar Pradesh, India.

The registered office of Uniqlife Biosciences is at Satyam Multiplex Office No. 7 First Floor 103 Sector 12A Avas Vikas Colony, Agra, Uttar Pradesh, India – 282007.

Uniqlife Biosciences operates in the pharma industry, in the drug formulation and development segment.